Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Encorafenib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Braftovi 50mg capsules
0801050CMBBABAB
|
Braftovi | Encorafenib | Malignant Disease and Immunosuppression | No data available |
|
Braftovi 75mg capsules
0801050CMBBAAAA
|
Braftovi | Encorafenib | Malignant Disease and Immunosuppression | No data available |
|
Encorafenib 50mg capsules
0801050CMAAABAB
|
Encorafenib | Encorafenib | Malignant Disease and Immunosuppression | No data available |
|
Encorafenib 75mg capsules
0801050CMAAAAAA
|
Encorafenib | Encorafenib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.